CRISPR Concerns Won’t Spoil Its Promise—If We Use the Right Tools
GEN,
The recent approval by the U.S. Food and Drug Administration (FDA) of Casgevy, a therapy developed by Vertex Pharmaceuticals…
The recent approval by the U.S. Food and Drug Administration (FDA) of Casgevy, a therapy developed by Vertex Pharmaceuticals…
Published: Jul 10, 2023 By Natalia Mesa BioSpace Hereditary angioedema patients treated with Intellia’s NTLA-2002—an in vivo…
Pictured: CRISPR-Cas9 genome editing enzyme/iStock, Artur Plawgo Hereditary angioedema patients treated with Intellia’s NTLA-2002…
Today’s gene therapies have huge potential — they have worked in treating certain cancers, along with blood and vision diseases …